Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
28 Jun 2024  |  Global  |  Market Research
Remote Patient Monitoring Sector Driving Transformational Growth through Strategic Partnerships: Forecast Global, 2024 2028
Industry Convergence and Digitalization Intensify the Competitive Environment
Remote patient monitoring (RPM) encompasses devices and IT infrastructure designed to enable clinicians to collect and monitor patients' biometric data and behaviors remotely. This infrastructure includes software, gateways, platforms, data transmission and management systems, and networks. While consumer-grade wearables, including smartphones, sma...
$4,950.00 -
25 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029
Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential
By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...
$4,950.00 -
19 Jun 2024  |  Global  |  Technology Research
Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024 2028
Leveraging integrated and point-of-care diagnostics with multiomics represents the most promising growth opportunity to advance molecular diagnostics for neurodegenerative diseases
Neurodegenerative diseases (NDD) pose significant challenges to healthcare systems and affect millions of people worldwide, making early detection crucial. While the current diagnostic strategy is predominantly brain imaging techniques, it is not performed until symptoms are more pronounced. Subtle changes occurring in neural cells during early pro...
$4,950.00 -
17 Jun 2024  |  Global  |  Market Research
Diagnostics Lab Automation and Monitoring Solutions Growth Opportunities
The Intersection of Automation and Digital Data Exchange Unlocks Value for Diagnostics Labs
The pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources are persistent challenges for the diagnostics sector. Lab test results are the foundation of future human health, influencing 70% of clinical decisions. A surge in lab tests yearly volume will result from persistent trends, including aging popu...
$4,950.00 -
14 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028
GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth
Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...
$4,950.00 -
12 Jun 2024  |  Global  |  Technology Research
Smartphone-based Point-of-care Testing Innovations and Growth Opportunities
Growth Potential Enhanced by Advanced AI/ML Algorithms and Miniaturized Molecular Diagnostics
Smartphone-based point-of-care (POC) diagnostics are rapidly emerging as medical diagnostics, enabling remote or self-monitoring tools for general wellness and a range of health conditions. Smartphones enable low-cost, rapid, and handy POC diagnostics. Intrinsic sensors of smartphones or extrinsic sensing devices working with intelligent data analy...
$4,950.00 -
12 Jun 2024  |  Global  |  Market Research
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities
The Integration of Real-world Insights into Trial Management is Propelling AI Adoption in Clinical Trials
As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...
$2,450.00 -
11 Jun 2024  |  Global  |  Market Research
Global Sports Medicine Industry, Forecast to 2028
Medical Advancements in Treating, Diagnosing, and Preventing Injuries Creates Growth Opportunities
This Frost & Sullivan analysis covers innovative devices propelling industry growth as well as market trends and emerging business models that will dominate the sports medicine sector. It highlights the dominating solutions in the sports medicine devices industry, including body reconstruction and body support and recovery devices, as well as compa...
$4,950.00 -
31 May 2024  |  Global  |  Market Research
Diabetes Care Devices, Forecast to 2028
Growth Opportunities in AI and GLP-1 will Drive the Expansion of Type 2 Diabetes Devices
This study provides a detailed overview of the global diabetes care device industry, which is witnessing a significant increase in demand due to the growing prevalence of diabetes across regions. The market, comprising both established players and emerging start-ups, is the site of fierce competition. OEMs are developing innovative, AI-equipped tec...
$4,950.00 -
29 May 2024  |  Global  |  Technology Research
Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics)
Rising Popularity Among Tier 1 Pharma Companies and Technological Advances in Drug Delivery Push Biologics Development
There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...
$4,950.00